Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentAsset Writedowns and ImpairmentDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowNet Cash FlowNet Cash FlowNet IncomeShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Intelligent Bio Solutions (INBS) Change in Accured Expenses (2022 - 2025)

Intelligent Bio Solutions has reported Change in Accured Expenses over the past 3 years, most recently at -$219399.0 for Q1 2024.

  • For Q1 2024, Change in Accured Expenses fell 17750.76% year-over-year to -$219399.0; the TTM value through Mar 2024 reached -$214345.0, down 1746.21%, while the annual FY2023 figure was -$25724.0, 189.15% down from the prior year.
  • Change in Accured Expenses for Q1 2024 was -$219399.0 at Intelligent Bio Solutions, down from $2261.0 in the prior quarter.
  • Over five years, Change in Accured Expenses peaked at $14077.0 in Q2 2022 and troughed at -$219399.0 in Q1 2024.
  • A 3-year average of -$28244.4 and a median of $1752.0 in 2023 define the central range for Change in Accured Expenses.
  • Biggest five-year swings in Change in Accured Expenses: skyrocketed 109.49% in 2023 and later tumbled 17750.76% in 2024.
  • Year by year, Change in Accured Expenses stood at $2905.0 in 2022, then fell by 22.17% to $2261.0 in 2023, then tumbled by 9803.63% to -$219399.0 in 2024.
  • Business Quant data shows Change in Accured Expenses for INBS at -$219399.0 in Q1 2024, $2261.0 in Q4 2023, and $2830.0 in Q3 2023.